Maintenance of Stemness in Oxaliplatin-Resistant Hepatocellular Carcinoma Is Associated with Increased Autocrine of IGF1-Reference-Cited by-同舟云学术

Maintenance of Stemness in Oxaliplatin-Resistant Hepatocellular Carcinoma Is Associated with Increased Autocrine of IGF1

Published:2014-03-14 Issue:3 Volume:9 Page:e89686
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bu Yang,Jia Qing-An,Ren Zheng-Gang,Zhang Ju-Bo,Jiang Xue-Mei,Liang Lei,Xue Tong-Chun,Zhang Quan-Bao,Wang Yan-Hong,Zhang Lan,Xie Xiao-Ying,Tang Zhao-You

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Global cancer statistics;A Jemal;CA Cancer J Clin,2011

2. Current approaches to the treatment of early hepatocellular carcinoma;SL Ye;Oncologist,2010

3. Chemoembolization for hepatocellular carcinoma;J Bruix;Gastroenterology,2004

4. Hepatocellular carcinoma;HB El-Serag;N Engl J Med,2011

5. Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium Trial;Y Yen;Am J Clin Oncol,2008

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of IGF/IGF-1R signaling in the regulation of cancer stem cells;Clinical and Translational Oncology;2024-06-12

2. NLRP3/IL‐1β induced myeloid‐derived suppressor cells recruitment and PD‐L1 upregulation promotes oxaliplatin resistance of hepatocellular carcinoma;MedComm;2023-12

3. Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment;Cellular and Molecular Gastroenterology and Hepatology;2023

4. SP1-induced lncRNA DUBR promotes stemness and oxaliplatin resistance of hepatocellular carcinoma via E2F1-CIP2A feedback;Cancer Letters;2022-03

5. LncRNA PCGEM1 mediates oxaliplatin resistance in hepatocellular carcinoma via miR-129-5p/ETV1 axis in vitro;Advances in Clinical and Experimental Medicine;2021-07-20